Data / Form D filings / VIVEVE MEDICAL, INC.
VIVEVE MEDICAL, INC.: Form D filings
VIVEVE MEDICAL, INC., a biotechnology company in Englewood, CO, filed 13 Form D notices with the SEC between 2011 and 2022. The latest, on October 27, 2022, reports $14,675 sold of a $14,675 offering to 1 investor.
Find out what VIVEVE MEDICAL, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 345 INVERNESS DRIVE SOUTH, BUILDING B, SUITE 250, Englewood, CO, 80112
- Phone
- (720) 696-8100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 879682
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2022 | New notice | $14,675 | $14,675 | $0 | 1 | Oct 14, 2022 | sec.gov |
| Jun 18, 2020 | New notice | $10,000,000 | $341,250 | $9,658,750 | 1 | Jun 9, 2020 | sec.gov |
| May 4, 2020 | New notice | $3,225,875 | $3,225,875 | $0 | 9 | Apr 20, 2020 | sec.gov |
| Dec 3, 2015 | New notice | $6,001,369 | $6,001,369 | $0 | 12 | Nov 24, 2015 | sec.gov |
| May 27, 2015 | New notice | $12,000,000 | $12,000,000 | $0 | 20 | May 14, 2015 | sec.gov |
| Oct 8, 2014 | New notice | $2,411,081 | $2,411,081 | $0 | 23 | Sep 23, 2014 | sec.gov |
| Jun 10, 2014 | New notice | $750,000 | $500,000 | $250,000 | 1 | Apr 14, 2014 | sec.gov |
| Jun 4, 2014 | New notice | $6,000,000 | $6,000,000 | $0 | 28 | May 9, 2014 | sec.gov |
| Sep 27, 2013 | New notice | $3,750,000 | $1,750,000 | $2,000,000 | 7 | Sep 18, 2013 | sec.gov |
| Feb 25, 2013 | New notice | $11,250,000 | $4,040,000 | $7,210,000 | 27 | Feb 22, 2013 | sec.gov |
| Jan 17, 2013 | New notice | $250,000 | $250,000 | $0 | 1 | Jan 16, 2013 | sec.gov |
| Jul 9, 2012 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Jul 2, 2012 | sec.gov |
| Mar 8, 2011 | New notice | $4,000,000 | $4,000,000 | $0 | 1 | Feb 22, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sharon Presnell | Director | |
| Arlene Morris | Director | |
| Steven Basta | Director | |
| Jim Robbins | Executive Officer | |
| Debora Jorn | Director | |
| Scott Durbin | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Oct 24, 2022 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VIVEVE MEDICAL, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.